Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer

被引:4
作者
Li, Jie [1 ,2 ]
Wu, Yao [3 ,4 ]
Li, Yongping [5 ]
Zhu, Hongbo [5 ]
Zhang, Zhiwen [3 ,4 ]
Li, Yaping [1 ,2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China
[3] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[4] Fudan Univ, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
[5] Fudan Univ, Shanghai Pudong Hosp, Pudong Med Ctr, Dept Breast Surg, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
glutathione; glutathioneperoxidase; 4; ferroptosis; nanotherapeutics; triple-negative breast cancer; CELL-DEATH; PH;
D O I
10.1021/acsnano.4c04322
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The refractory luminal androgen receptor (LAR) subtype of triple-negative breast cancer (TNBC) patients is challenged by significant resistance to neoadjuvant chemotherapy and increased immunosuppression. Regarding the distinct upregulation of glutathione (GSH) and glutathione peroxidase 4 (GPX4) in LAR TNBC tumors, we herein designed a GSH-depleting phospholipid derivative (BPP) and propose a BPP-based nanotherapeutics of RSL-3 (GDNS), aiming to deplete intracellular GSH and repress GPX4 activity, thereby potentiating ferroptosis for treating LAR-subtype TNBC. GDNS treatment drastically downregulated the expression of GSH and GPX4, resulting in a 33.88-fold enhancement of lipid peroxidation and significant relief of immunosuppression in the 4T1 TNBC model. Moreover, GDNS and its combination with antibody against programed cell death protein 1 (antiPD-1) retarded tumor growth and produced 2.83-fold prolongation of survival in the LAR-positive TNBC model. Therefore, the GSH-disrupting GDNS represents an encouraging strategy to potentiate ferroptosis for treating refractory LAR-subtype TNBC.
引用
收藏
页码:26585 / 26599
页数:15
相关论文
共 43 条
[1]   Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion [J].
Angeli, Jose Pedro Friedmann ;
Krysko, Dmitri, V ;
Conrad, Marcus .
NATURE REVIEWS CANCER, 2019, 19 (07) :405-414
[2]   Glutathione metabolism in cancer progression and treatment resistance [J].
Bansal, Ankita ;
Simon, M. Celeste .
JOURNAL OF CELL BIOLOGY, 2018, 217 (07) :2291-2298
[3]   Treatment landscape of triple-negative breast cancer - expanded options, evolving needs [J].
Bianchini, Giampaolo ;
De Angelis, Carmine ;
Licata, Luca ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) :91-113
[4]   Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy [J].
Cheng, Xiaotong ;
Xu, Hai-Dong ;
Ran, Huan-Huan ;
Liang, Gaolin ;
Wu, Fu-Gen .
ACS NANO, 2021, 15 (05) :8039-8068
[5]   The chemical basis of ferroptosis [J].
Conrad, Marcus ;
Pratt, Derek A. .
NATURE CHEMICAL BIOLOGY, 2019, 15 (12) :1137-1147
[6]   The matrix in cancer [J].
Cox, Thomas R. .
NATURE REVIEWS CANCER, 2021, 21 (04) :217-238
[7]   The role of iron and reactive oxygen species in cell death [J].
Dixon, Scott J. ;
Stockwell, Brent R. .
NATURE CHEMICAL BIOLOGY, 2014, 10 (01) :9-17
[8]   Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles [J].
Eaton, John K. ;
Furst, Laura ;
Ruberto, Richard A. ;
Moosmayer, Dieter ;
Hilpmann, Andre ;
Ryan, Matthew J. ;
Zimmermann, Katja ;
Cai, Luke L. ;
Niehues, Michael ;
Badock, Volker ;
Kramm, Anneke ;
Chen, Sixun ;
Hillig, Roman C. ;
Clemons, Paul A. ;
Gradl, Stefan ;
Montagnon, Claire ;
Lazarski, Kiel E. ;
Christian, Sven ;
Bajrami, Besnik ;
Neuhaus, Roland ;
Eheim, Ashley L. ;
Viswanathan, Vasanthi S. ;
Schreiber, Stuart L. .
NATURE CHEMICAL BIOLOGY, 2020, 16 (05) :497-+
[9]   Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification [J].
Echavarria, Isabel ;
Lopez-Tarruella, Sara ;
Picornell, Antoni ;
Angel Garcia-Saenz, Jose ;
Jerez, Yolanda ;
Hoadley, Katherine ;
Gomez, Henry L. ;
Moreno, Fernando ;
Del Monte-Millan, Maria ;
Marquez-Rodas, Ivan ;
Alvarez, Enrique ;
Ramos-Medina, Rocio ;
Gayarre, Javier ;
Massarrah, Tatiana ;
Ocana, Inmaculada ;
Cebollero, Maria ;
Fuentes, Hugo ;
Barnadas, Agusti ;
Isabel Ballesteros, Ana ;
Bohn, Uriel ;
Perou, Charles M. ;
Martin, Miguel .
CLINICAL CANCER RESEARCH, 2018, 24 (08) :1845-1852
[10]   Triggered Degradable Colloidal Particles with Ordered Inverse Bicontinuous Cubic and Hexagonal Mesophases [J].
Fan, Bo ;
Wan, Jing ;
Zhai, Jiali ;
Chen, Xiaoyu ;
Thang, San H. .
ACS NANO, 2021, 15 (03) :4688-4698